ABT,Abbott India says to comply with government order on drugs banAbbott India says to comply with government order on drugs banAntibiotic combination marketed by Abbott in India on list of banned drugsCORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.      CORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     MUMBAI A powerful antibiotic combination that is marketed in India by U.S. pharmaceutical giant Abbott Laboratories is among 344 drug combinations that have been banned by the Indian health authorities.CORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.       Antibiotic combination marketed by Abbott in India on list of banned drugsCORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.      CORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     MUMBAI A powerful antibiotic combination that is marketed in India by U.S. pharmaceutical giant Abbott Laboratories is among 344 drug combinations that have been banned by the Indian health authorities.CORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.      NEW DELHI U.S.-pharmaceutical giant Abbott Laboratories' India unit   will comply with all legal requirements of a government order that bans more than 300 combination drugs in the country, a company spokesman said on Monday.Antibiotic combination marketed by Abbott in India on list of banned drugsCORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.      CORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     MUMBAI A powerful antibiotic combination that is marketed in India by U.S. pharmaceutical giant Abbott Laboratories is among 344 drug combinations that have been banned by the Indian health authorities.CORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.        Abbott India says to comply with government order on drugs banAntibiotic combination marketed by Abbott in India on list of banned drugsCORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.      CORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     MUMBAI A powerful antibiotic combination that is marketed in India by U.S. pharmaceutical giant Abbott Laboratories is among 344 drug combinations that have been banned by the Indian health authorities.CORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.       Antibiotic combination marketed by Abbott in India on list of banned drugsCORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.      CORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     MUMBAI A powerful antibiotic combination that is marketed in India by U.S. pharmaceutical giant Abbott Laboratories is among 344 drug combinations that have been banned by the Indian health authorities.CORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.      NEW DELHI U.S.-pharmaceutical giant Abbott Laboratories' India unit   will comply with all legal requirements of a government order that bans more than 300 combination drugs in the country, a company spokesman said on Monday.Antibiotic combination marketed by Abbott in India on list of banned drugsCORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.      CORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     MUMBAI A powerful antibiotic combination that is marketed in India by U.S. pharmaceutical giant Abbott Laboratories is among 344 drug combinations that have been banned by the Indian health authorities.CORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.       NEW DELHI, March 14 U.S.-pharmaceutical giant Abbott Laboratories' India unit  will comply with all legal requirements of a government order that bans more than 300 combination drugs in the country, a company spokesman said on Monday.Abbott India says to comply with government order on drugs banAntibiotic combination marketed by Abbott in India on list of banned drugsCORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.      CORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     MUMBAI A powerful antibiotic combination that is marketed in India by U.S. pharmaceutical giant Abbott Laboratories is among 344 drug combinations that have been banned by the Indian health authorities.CORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.       Antibiotic combination marketed by Abbott in India on list of banned drugsCORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.      CORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     MUMBAI A powerful antibiotic combination that is marketed in India by U.S. pharmaceutical giant Abbott Laboratories is among 344 drug combinations that have been banned by the Indian health authorities.CORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.      NEW DELHI U.S.-pharmaceutical giant Abbott Laboratories' India unit   will comply with all legal requirements of a government order that bans more than 300 combination drugs in the country, a company spokesman said on Monday.Antibiotic combination marketed by Abbott in India on list of banned drugsCORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.      CORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     MUMBAI A powerful antibiotic combination that is marketed in India by U.S. pharmaceutical giant Abbott Laboratories is among 344 drug combinations that have been banned by the Indian health authorities.CORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.     UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.    Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.   Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.Indian court grants Pfizer temporary relief on cough syrup banFDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.  FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.FDA advisers to weigh risks of Abbott's dissolving stent March 14 U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.        
BAC,Bank of America wins round in ongoing pension-plan dispute A federal court sided with Bank of America Corp in a long-running battle over employee pensions on Friday, scheduling a November trial to determine whether the bank retained profits from a discredited investment strategy that led to a $10 million fine from the Internal Revenue Service. 
CBS,Viacom shareholders re-elect directors, reject voting rights proposalBRIEF-Viacom CEO says Sumner Redstone enjoying life and getting best medical careViacom shareholders re-elect directors, reject voting rights proposalUPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.   UPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.UPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.    Viacom shareholders re-elect directors, reject voting rights proposalUPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.   UPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.UPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.   * Ceo dauman says did not seek to be in charge of Sumner Redstone's health care directiveViacom shareholders re-elect directors, reject voting rights proposalUPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.   UPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.UPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.     BRIEF-Viacom CEO says Sumner Redstone enjoying life and getting best medical careViacom shareholders re-elect directors, reject voting rights proposalUPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.   UPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.UPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.    Viacom shareholders re-elect directors, reject voting rights proposalUPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.   UPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.UPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.   * Ceo dauman says did not seek to be in charge of Sumner Redstone's health care directiveViacom shareholders re-elect directors, reject voting rights proposalUPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.   UPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.UPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.    March 14 Viacom Inc investors re-elected the media company's directors and rejected a proposal to extend voting rights to all shareholders despite recommendations by the leading proxy advisory firm to withhold support for some directors and approve the proposal.BRIEF-Viacom CEO says Sumner Redstone enjoying life and getting best medical careViacom shareholders re-elect directors, reject voting rights proposalUPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.   UPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.UPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.    Viacom shareholders re-elect directors, reject voting rights proposalUPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.   UPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.UPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.   * Ceo dauman says did not seek to be in charge of Sumner Redstone's health care directiveViacom shareholders re-elect directors, reject voting rights proposalUPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.   UPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.UPDATE 4-Viacom shareholders re-elect directors, reject voting rights proposalViacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.  Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm. MIAMI, March 14 A substantial majority of Viacom Inc's independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.Viacom shareholders re-elect directors, reject voting rights proposal MIAMI A substantial majority of Viacom Inc's  independent shareholders on Monday voted to re-elect the media company's directors and rejected a move to extend voting rights to all shareholders, going against recommendations by the leading proxy advisory firm.     
F,Early March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector. 
GM,Plaintiffs face critical legal tests in GM ignition-switch casesPlaintiffs face critical legal tests in GM ignition-switch casesRPT-Plaintiffs face critical legal tests in GM ignition-switch casesEarly March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector.  Early March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector. NEW YORK, March 14 People suing General Motors Co over a faulty ignition switch will get two chances in a Manhattan court this week to argue that the U.S. automaker should be held accountable for injuries, deaths and lost vehicle value.Early March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector.   RPT-Plaintiffs face critical legal tests in GM ignition-switch casesEarly March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector.  Early March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector. NEW YORK, March 14 People suing General Motors Co over a faulty ignition switch will get two chances in a Manhattan court this week to argue that the U.S. automaker should be held accountable for injuries, deaths and lost vehicle value.Early March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector.  NEW YORK People suing General Motors Co  over a faulty ignition switch will get two chances in a Manhattan court this week to argue that the U.S. automaker should be held accountable for injuries, deaths and lost vehicle value.RPT-Plaintiffs face critical legal tests in GM ignition-switch casesEarly March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector.  Early March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector. NEW YORK, March 14 People suing General Motors Co over a faulty ignition switch will get two chances in a Manhattan court this week to argue that the U.S. automaker should be held accountable for injuries, deaths and lost vehicle value.Early March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector.    Plaintiffs face critical legal tests in GM ignition-switch casesRPT-Plaintiffs face critical legal tests in GM ignition-switch casesEarly March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector.  Early March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector. NEW YORK, March 14 People suing General Motors Co over a faulty ignition switch will get two chances in a Manhattan court this week to argue that the U.S. automaker should be held accountable for injuries, deaths and lost vehicle value.Early March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector.   RPT-Plaintiffs face critical legal tests in GM ignition-switch casesEarly March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector.  Early March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector. NEW YORK, March 14 People suing General Motors Co over a faulty ignition switch will get two chances in a Manhattan court this week to argue that the U.S. automaker should be held accountable for injuries, deaths and lost vehicle value.Early March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector.  NEW YORK People suing General Motors Co  over a faulty ignition switch will get two chances in a Manhattan court this week to argue that the U.S. automaker should be held accountable for injuries, deaths and lost vehicle value.RPT-Plaintiffs face critical legal tests in GM ignition-switch casesEarly March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector.  Early March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector. NEW YORK, March 14 People suing General Motors Co over a faulty ignition switch will get two chances in a Manhattan court this week to argue that the U.S. automaker should be held accountable for injuries, deaths and lost vehicle value.Early March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector.   NEW YORK, March 14 People suing General Motors Co over a faulty ignition switch will get two chances in a Manhattan court this week to argue that the U.S. automaker should be held accountable for injuries, deaths and lost vehicle value.Plaintiffs face critical legal tests in GM ignition-switch casesRPT-Plaintiffs face critical legal tests in GM ignition-switch casesEarly March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector.  Early March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector. NEW YORK, March 14 People suing General Motors Co over a faulty ignition switch will get two chances in a Manhattan court this week to argue that the U.S. automaker should be held accountable for injuries, deaths and lost vehicle value.Early March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector.   RPT-Plaintiffs face critical legal tests in GM ignition-switch casesEarly March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector.  Early March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector. NEW YORK, March 14 People suing General Motors Co over a faulty ignition switch will get two chances in a Manhattan court this week to argue that the U.S. automaker should be held accountable for injuries, deaths and lost vehicle value.Early March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector.  NEW YORK People suing General Motors Co  over a faulty ignition switch will get two chances in a Manhattan court this week to argue that the U.S. automaker should be held accountable for injuries, deaths and lost vehicle value.RPT-Plaintiffs face critical legal tests in GM ignition-switch casesEarly March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector.  Early March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector. NEW YORK, March 14 People suing General Motors Co over a faulty ignition switch will get two chances in a Manhattan court this week to argue that the U.S. automaker should be held accountable for injuries, deaths and lost vehicle value.Early March gains in auto sector shares may prove fleeting NEW YORK, March 14 Auto stocks have come roaring out of the gate in the last month, but the gains may be short-lived as analysts and investors show signs of souring on the sector.    
GS,REFILE-Goldman revamps electronic stock trading to catch rival NEW YORK, March 14 Raj Mahajan achieved a rare feat when he rejoined Goldman Sachs Group Inc last year with the coveted title of partner, the Wall Street bank's highest rank. Then he got to work on fixing the pipes. 
K,FDA investigating graphic video linked to Kellogg factory March 14 Breakfast cereals maker Kellogg Co  said federal regulators are conducting a criminal investigation of a video that surfaced on Friday showing a man filming himself urinating on one of its factory assembly lines. 
PFE,Pfizer stops selling popular Corex cough syrup in India after banCORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.  Indian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans. * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.   UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.  Indian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans. * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.  MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.  Indian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans. * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.    CORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.  Indian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans. * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.   UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.  Indian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans. * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.  MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.  Indian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans. * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.   MUMBAI, March 14 U.S. pharmaceutical giant Pfizer Inc's India unit said on Monday it had stopped selling its popular Corex cough syrup, after regulators banned it saying it was likely to pose a risk to humans.CORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrupUPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.  Indian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans. * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.   UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.  Indian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans. * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.  MUMBAI/NEW DELHI, March 14 An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's   Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers representing the drugmaker told Reuters.UPDATE 4-Indian court grants Pfizer temporary relief on cough syrup banIndian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.  Indian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans. * Pfizer says banned syrup brought in $26 mln in Apr-Dec   (Adds statement from Pfizer's India unit)Indian court grants Pfizer temporary relief on cough syrup ban MUMBAI/NEW DELHI An Indian court granted U.S. drugmaker Pfizer   an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.    
UAL,Activist investors question United Airlines CEO's board role, pay NEW YORK, March 14 The two hedge funds that launched a boardroom fight with United Continental Holdings Inc  last week oppose the airline's plans to give Chief Executive Oscar Munoz the additional role of chairman and have concerns about his compensation, according to a person familiar with the matter. 
VZ,New York Times' editorial page editor Andrew Rosenthal to step down New York Times Co said on Monday Andrew Rosenthal would step down as the newspaper's editorial page editor in late April, and would be succeeded by James Bennet, editor-in-chief of the Atlantic. 
